back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-10-02 09:18 Tx date 2025-09-30 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$6,554
+568 vol $11.54 each |
180,147 | |
| Filed 2025-10-02 09:17 Tx date 2025-09-30 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-1,137 vol |
179,579 | |
| Filed 2025-07-06 12:08 Tx date 2025-06-30 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$6,678
+566 vol $11.80 each |
180,716 | |
| Filed 2025-07-06 12:06 Tx date 2025-06-30 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-1,132 vol |
180,150 | |
| Filed 2025-05-23 16:08 Tx date 2025-05-23 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,390
-200 vol $11.95 each |
181,282 | |
| Filed 2025-05-23 16:07 Tx date 2025-05-23 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-751.59
-63 vol $11.93 each |
181,482 | |
| Filed 2025-05-23 16:06 Tx date 2025-05-23 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,185
-100 vol $11.85 each |
181,545 | |
| Filed 2025-05-22 16:42 Tx date 2025-05-22 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,350
-200 vol $11.75 each |
181,645 | |
| Filed 2025-04-01 15:47 Tx date 2025-03-31 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$6,277
+563 vol $11.15 each |
181,845 | |
| Filed 2025-04-01 15:46 Tx date 2025-03-31 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-1,127 vol |
181,282 | |
| Filed 2025-03-21 12:54 Tx date 2025-03-21 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-450.00
-40 vol $11.25 each |
182,409 | |
| Filed 2025-03-19 16:56 Tx date 2025-03-19 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,625
-500 vol $11.25 each |
182,449 | |
| Filed 2025-03-19 12:18 Tx date 2025-03-18 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+4,200 vol |
182,949 | |
| Filed 2025-03-19 12:16 Tx date 2025-03-18 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,125
-100 vol $11.25 each |
178,749 | |
| Filed 2025-03-11 16:33 Tx date 2024-12-31 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,762
+309 vol $8.94 each |
178,849 | |
| Filed 2025-01-02 14:23 Tx date 2024-12-31 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$7,040
+640 vol $11.00 each |
178,540 | |
| Filed 2025-01-02 14:22 Tx date 2024-12-31 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,281 vol |
177,900 | |
| Filed 2024-11-26 17:46 Tx date 2024-11-25 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,293.65
-637 vol $11.45 each |
176,619 | |
| Filed 2024-10-01 11:33 Tx date 2024-09-30 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$6,822
+637 vol $10.71 each |
177,256 | |
| Filed 2024-10-01 11:32 Tx date 2024-09-30 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-1,275 vol |
176,619 |